Morepen Laboratories Ltd Share Price
(MOREPENLAB)
₹62.63▲0.93%
as on 04:01PM, 29 Apr 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 26.83 % |
3 Month Return | + 0.3 % |
1 Year Return | + 25.13 % |
Market Stats | |
Previous Close | ₹62.05 |
Open | ₹62.28 |
Volume | 98.88L |
Upper Circuit | ₹74.46 |
Lower Circuit | ₹49.64 |
Market Cap | ₹3,431.83Cr |
P/E Ratio
26.21
PEG Ratio
29.44
Market Cap
₹3,431.83 Cr
P/B Ratio
2.42
EPS
1.89
Dividend Yield
0Sector
Pharmaceuticals
ROE
13.29
Funds | Holdings | Prev. 5M |
---|---|---|
![]() | 0.14% |
Morepen Laboratories Stock Soars on Growth Plans - 24 Apr, 2025
Morepen Labs Aims for Rs 5,000 Crore Revenue by FY30 - 19 Apr, 2025
Morepen Laboratories Expands Salesforce Significantly - 11 Apr, 2025
Morepen Secures China Approval for Loratadine API - 01 Apr, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, MOREPENLAB stock has moved up by 13.9%
Retail Holding Up
Retail Investor have increased holdings from 60.47% to 60.72% in Mar 2025 quarter
Revenue Rich
Revenue is up for the last 2 quarters, 442.71 Cr → 458.12 Cr (in ₹), with an average increase of 3.4% per quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 35.65% of holdings in Mar 2025 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.0% return, outperforming this stock by 109.3%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 51.1% return, outperforming this stock by 28.3%
FII Holding Down
Foreign Institutions have decreased holdings from 2.22% to 1.94% in Mar 2025 quarter
Profit Down
Netprofit is down for the last 3 quarters, 36.17 Cr → 26.69 Cr (in ₹), with an average decrease of 13.5% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 35.65% | 0.00 | |
Foreign Institutions | 1.94% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 60.72% | 0.00 | |
Others | 1.68% | 0.00 |
Morepen Laboratories in the last 5 years
Lowest (10.48x)
March 23, 2020
Today (26.21x)
April 29, 2025
Industry (54.77x)
April 29, 2025
Highest (64.70x)
January 22, 2018
Morepen Laboratories Ltd’s net profit fell -16.57% since last year same period to ₹26.69Cr in the Q3 2024-2025. On a quarterly growth basis, Morepen Laboratories Ltd has generated -23.41% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Morepen Laboratories Ltd is currently in a Bullish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹3,431.83 Cr | 48.45% | 0.53 | ₹96 Cr | ₹1,690 Cr | |
NA | ₹147.07 Cr | 35.43% | 0.62 | NA | NA | |
NA | ₹5,411.31 Cr | 432.02% | 0.50 | ₹33 Cr | ₹204 Cr | |
NA | ₹1,510.04 Cr | 381.87% | 0.52 | NA | NA | |
NA | ₹3,596.41 Cr | 157.18% | 0.51 | NA | NA |
Organisation | Morepen Laboratories |
Headquarters | Gurgaon |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Morepen Laboratories Ltd share price today stands at ₹62.63, Open: ₹62.28, Previous Close: ₹62.05, High: ₹63.37, Low: ₹61.38, 52 Week High: ₹100.9, 52 Week Low: ₹42.
Today's traded volume of Morepen Laboratories Ltd(MOREPENLAB) is 98.88L.
Today's market capitalisation of Morepen Laboratories Ltd(MOREPENLAB) is ₹3431.83Cr.
Morepen Laboratories Ltd (MOREPENLAB) share price is ₹62.63. It is down -37.93% from its 52 Week High price of ₹100.9
Morepen Laboratories Ltd (MOREPENLAB) share price is ₹62.63. It is up 49.12% from its 52 Week Low price of ₹42